CClinicalTrials.gg
CompletedNCT05591313Updated Feb 8, 2023

Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD

An interventional study of LI-40 and MI-30 in Alzheimer Disease 2 Due to Apoe4 Isoform, sponsored by National Taiwan Normal University. Completed at 1 site in Taiwan. Open to participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by National Taiwan Normal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 4 months after the study started (first participant enrolled May 2016, registered Oct 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
50 Years to 70 Years
Sex
All
01

Study summary

This study explores the acute exercise effect on neurocognitive function and also its potential moderators in an exercise setting and Apolipoprotein E (APOE) genetic risk.

Read the detailed description

Acute exercise has emerged as a modifier to multiple aspects of cognitive function; however, its effect on populations with different risks of Alzheimer's disease (AD) and the role of exercise variance and APOE genotype within the effect reminds underestimated. The current study aimed to examine the acute exercise effect on neurocognitive function from behavioral and neuroelectric perspectives among cognitively normal late-middle-aged adults. Additionally, we determined whether variations in exercise intensity and duration and the presence of the APOE ɛ4 allele modulated the effect.

02

Conditions studied

  • Alzheimer Disease 2 Due to Apoe4 Isoform

Browse trials for

Keywords

  • aerobic exercise
  • APOE genotype
  • event-related potential
  • executive function
  • exercise prescription
03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's enrollment of 51 is below the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

National Taiwan Normal University is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Adults aged between 50 and 70 years old
  2. Normal or corrected-to-normal vision based on the minimal 20/20 standard
  3. Cognitively normal as mini-mental state examination scores (MMSE) > 26

Exclusion criteria

Exclusion Criteria:

  1. Neurological or psychiatric disorders
  2. Cardiovascular disease
  3. Risk of cardiovascular fitness assessment based on the Physical Activity Readiness Questionnaire (PAR-Q)
  4. Red-green color blindness.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Low-intensity with longer duration (40-min) exercise (LI-40)

    The participants were instructed to complete a volume-matched low-intensity with longer duration (40-min) exercise (LI-40) treatment.

    Behavioral: LI-40

  • Experimental
    Moderate-intensity with 30 min exercise (MI-30)

    The participants were instructed to complete a volume-matched moderate-intensity with 30 min exercise (MI-30) treatment.

    Behavioral: MI-30

  • Experimental
    High-intensity with shorter duration (16-min) exercise (HI-16)

    The participants were instructed to complete a volume-matched high-intensity with shorter duration (16-min) exercise (HI-16) treatment.

    Behavioral: HI-16

  • No intervention
    Control treatment (CON)

    The participants in the control treatment (CON) were instructed to complete book reading for 30-min.

Interventions

  • BehavioralLI-40

    Participants were asked to complete a volume-matched light-intensity exercise for 30-min. The exercise volume was pre-determined based on the energy expenditure (kcal) calculated with 5-min warm-up stage, 20-min main exercise stage (i.e., moderate intensity as 50%-60 % heart rate reserve, HRR), and 5-min cool-down stage.

    Also known as: Light intensity 40-min exercise

  • BehavioralMI-30

    Participants were asked to complete a volume-matched moderate-intensity exercise for 20-min. The exercise volume was pre-determined based on the energy expenditure (kcal) calculated with 5-min warm-up stage, 20-min main exercise stage (i.e., moderate intensity as 50%-60 % heart rate reserve, HRR), and 5-min cool-down stage.

    Also known as: Moderate intensity 30-min exercise

  • BehavioralHI-16

    Participants were asked to complete a volume-matched high-intensity exercise for 16-min. The exercise volume was pre-determined based on the energy expenditure (kcal) calculated with 5-min warm-up stage, 20-min main exercise stage (i.e., moderate intensity as 50%-60 % heart rate reserve, HRR), and 5-min cool-down stage.

    Also known as: High intensity 16-min exercise

06

What researchers measure

Primary outcomes

  1. Stroop task: Response time

    A computerized Stroop task was used to assess participants' inhibitory control and basic information processing. The response time of the correct responses was calculated for the first behavioral index.

    Time frame: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

  2. Stroop task: Accuracy

    A computerized Stroop task was used to assess participants' inhibitory control and basic information processing. The accuracy was calculated for the second behavioral index.

    Time frame: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

  3. Event-related potential: P3 amplitude

    The event-related potential from parietal electrodes (i.e., P3, Pz, and P4) were initially outputted for the mean P3 amplitude; the averaged mean P3 amplitudes from parietal electrodes was then calculated as the neuroelectrical indices.

    Time frame: Participants were required to complete the Stroop task while EEG activity was continuously recorded approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

07

Study locations

1 site
  • Department of Physical Education and Sport Sciences, National Taiwan Normal University
    Taipei, 106308, Taiwan
08

References and documents

Individual participant data

Plan to share: No — Data are available upon request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05591313
Lead sponsor
National Taiwan Normal University
Responsible party
Yu-Kai Chang (Proffessor, National Taiwan Normal University) — Principal investigator
First posted
Oct 24, 2022
Start date
May 17, 2016
Primary completion
Sep 26, 2019
Completion
Sep 26, 2019
Last update
Feb 8, 2023

Study contacts

Yu-Kai Chang, Ph.D.
study director · Department of Physical Education and Sport Sciences, National Taiwan Normal University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion